Therapeutic uses of cannabigerol

Research output: Patent


The present invention relates to the use of the cannabinoid cannabigerol (CBG) in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from concurrent agonism of the CB1 and the CB2 cannabinoid receptors. Such diseases or conditions to be treated are taken from the group: pain, neurodegenerative disease, ischemic disease, brain injury or damage, acquired brain injury, age related inflammatory or autoimmune disease, cachexia, nausea and vomiting, glaucoma, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia and nephritis.
Original languageEnglish
Patent numberWO2009001081
IPCA61K31/352; A61K36/185; A61P25/28; (+3)
Publication statusPublished - 31 Dec 2008


Dive into the research topics of 'Therapeutic uses of cannabigerol'. Together they form a unique fingerprint.

Cite this